MayTech Global Investments’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
CS
MayTech Global Investments's BLUE Position: Q4 2020 in Review
MayTech Global Investments sold out of bluebird bio (BLUE) in Q4 2020, closing a stake of 55 shares — an estimated $39K sold.
MayTech Global Investments first reported a position in BLUE in Q4 2017 and held it in 12 quarters. The position peaked at $4.75M in Q1 2019. 262 funds tracked by Wall St. Rank hold BLUE as of Q4 2020.
- MayTech Global Investments reported no remaining bluebird bio position as of Q4 2020 after selling out during the quarter.
- MayTech Global Investments sold 55 bluebird bio shares in Q4 2020, an estimated $39K.
- MayTech Global Investments first reported a position in bluebird bio in Q4 2017 and held it in 12 quarters.
- MayTech Global Investments's bluebird bio position peaked at $4.75M in Q1 2019.
- 262 funds tracked by Wall St. Rank held bluebird bio as of Q4 2020.
Based on MayTech Global Investments's 13F filing for Q4 2020, filed 10 Feb 2021.